Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-08-02FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Sandoz's benazepril hydrochloride and hydrochlorothiazide, a generic fixed-dose combination for …
-
FDA approval · 2011-08-02FDA Approved: QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Quinapril Hydrchloride/Hydrochlorothiazide manufactured by Aurobindo Pharma Limited.
-
FDA approval · 2011-07-28FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for a benazepril hydrochloride and hydrochlorothiazide product from Sandoz Inc.
-
FDA approval · 2011-07-27FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved a supplemental application for amlodipine besylate from Teva Pharmaceuticals, Inc. under an ANDA.
-
FDA approval · 2011-07-26FDA Approved: CHLOROTHIAZIDE SODIUM — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' original application for CHLOROTHIAZIDE SODIUM, a thiazide diuretic, for the treatment of hypert…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-07-22FDA Approved: CAPTOPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for CAPTOPRIL from Hikma Pharmaceuticals USA Inc., indicating additional approval for this generic A…
-
FDA approval · 2011-07-21FDA Approved: PERINDOPRIL ERBUMINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic version of perindopril erbumine from Aurobindo Pharma Limited.
-
FDA approval · 2011-07-08FDA Approved: DOXAZOSIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for doxazosin (doxazosin mesylate) from Aurobindo Pharma Limited, updating the approved generic prod…
-
FDA approval · 2011-07-08FDA Approved: CARDURA XL — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Cardura XL (doxazosin mesylate) filed by Viatris Specialty LLC.
-
FDA approval · 2011-07-06FDA Approved: COREG — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for COREG (carvedilol) submitted by Waylis Therapeutics LLC, resulting in labeling updates for the d…
-
FDA approval · 2011-07-06FDA Approved: COREG CR — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for COREG CR (carvedilol phosphate) submitted by Waylis Therapeutics LLC. The action finalizes the r…
-
FDA approval · 2011-07-05FDA Approved: ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
The FDA approved a supplemental application for a generic fixed-dose combination of enalapril maleate and hydrochlorothiazide by Taro Pharma…
-
FDA approval · 2011-07-05FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin's generic fixed-dose combination of amlodipine besylate and benazepril hydrochloride for hypertension under an original A…
-
FDA approval · 2011-07-05FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Original Application (Dr.Reddy's Laboratories Limited)
FDA approves the original application for amlodipine besylate and benazepril hydrochloride tablets from Dr. Reddy's Laboratories Limited, a …
-
FDA approval · 2011-06-24FDA Approved: ATACAND — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental NDA for ATACAND (candesartan cilexetil), resulting in an updated product label. This acti…
-
FDA approval · 2011-06-20FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) from Novartis Pharmaceuticals Corporat…
-
FDA approval · 2011-06-14FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for candesartan cilexetil and hydrochlorothiazide by ANI Pharmaceuticals, Inc.
-
FDA approval · 2011-06-14FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for the benazepril hydrochloride and hydrochlorothiazide fixed-dose combination product from Padagis…
-
FDA approval · 2011-06-10FDA Approved: COZAAR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Cozaar (losartan potassium) filed by Organon LLC.
-
FDA approval · 2011-06-10FDA Approved: HYZAAR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for HYZAAR (losartan potassium and hydrochlorothiazide) from Organon LLC.
-
FDA approval · 2011-06-08FDA Approved: RAMIPRIL — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved Rising Pharma Holdings' original application for ramipril (generic ramipril), enabling the company to market a ramipril pro…
-
FDA approval · 2011-06-06FDA Approved: AVALIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for AVALIDE (irbesartan and hydrochlorothiazide) from Sanofi-Aventis U.S. LLC.
-
FDA approval · 2011-06-06FDA Approved: LOSARTAN POTASSIUM — Original Application (Solco Healthcare US, LLC)
The FDA approved Losartan Potassium as a generic product from Solco Healthcare US, LLC under original ANDA 091497.
-
FDA approval · 2011-05-19FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for BENICAR (olmesartan medoxomil) submitted by Cosette Pharmaceuticals, Inc., reflecting an approve…
-
FDA approval · 2011-05-19FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for AZOR (amlodipine besylate and olmesartan medoxomil) submitted by Cosette Pharmaceuticals, Inc. T…